(Q43836979)

English

Single-dose and steady-state pharmacokinetic and pharmacodynamic evaluation of therapeutically clinically equivalent doses of inhaled fluticasone propionate and budesonide, given as Diskus or Turbohaler dry-powder inhalers to healthy subjects

scientific article published in December 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Single-dose and steady-state pharmacokinetic and pharmacodynamic evaluation of therapeutically clinically equivalent doses of inhaled fluticasone propionate and budesonide, given as Diskus or Turbohaler dry-powder inhalers to healthy subjects (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

fluticasone propionate

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

Guenther Hochhaus

0 references

Hartmut Derendorf

13

object named as

Derendorf H

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

author name string

Möllmann H

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Wagner M

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Krishnaswami S

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Dimova H

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Tang Y

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Falcoz C

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Daley-Yates PT

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Krieg M

8

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Stöckmann R

9

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Barth J

10

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Lawlor C

11

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Möllmann AC

12

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Hochhaus G

14

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

1 December 2001

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

41

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1329-1338

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Therapeutic ratio of inhaled corticosteroids in adult asthma. A dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012913

21 January 2018

Determination of epimers 22R and 22S of budesonide in human plasma by high-performance liquid chromatography-atmospheric pressure chemical ionization mass spectrometry

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012913

21 January 2018

A sensitive LC-MS/MS method for the quantification of fluticasone propionate in human plasma.

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012913

21 January 2018

Pharmacokinetics of intravenous fluticasone propionate in healthy subjects

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012913

21 January 2018

The anti‐inflammatory profile of fluticasone propionate

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012913

21 January 2018

Pharmacologic importance of the reversible fatty acid conjugation of budesonide studied in a rat cell line In vitro

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012913

21 January 2018

Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012913

21 January 2018

Dose-proportional pharmacokinetics of budesonide inhaled via Turbuhaler

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012913

21 January 2018

A study comparing the clinical pharmacokinetics, pharmacodynamics, and tolerability of triamcinolone acetonide HFA-134a metered-dose inhaler and budesonide dry-powder inhaler following inhalation administration

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012913

21 January 2018

Hypothalamic-pituitary-adrenal axis suppression and inhaled corticosteroid therapy. 2. Review of the literature.

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012913

21 January 2018

Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012913

21 January 2018

Pharmacological factors that influence the choice of inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012913

21 January 2018

Pharmacokinetic and pharmacodynamic evaluation of fluticasone propionate after inhaled administration.

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012913

21 January 2018

Dynamic Modeling of Cortisol Reduction after Inhaled Administration of Fluticasone Propionate

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012913

21 January 2018

Bioavailability of orally administered micronised fluticasone propionate

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012913

21 January 2018

Rectal pharmacokinetics of budesonide

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012913

21 January 2018

Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012913

21 January 2018

Pharmacokinetic/pharmacodynamic aspects of aerosol therapy using glucocorticoids as a model

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012913

21 January 2018

Systemic exposure to fluticasone propionate administered via metered-dose inhaler containing chlorofluorocarbon or hydrofluoroalkane propellant

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012913

21 January 2018

Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler and Diskus powder devices in healthy volunteers

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012913

21 January 2018

Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012913

21 January 2018

Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler and Diskus powder devices in patients with mild-to-moderate asthma

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012913

21 January 2018

Comparison of the systemic availability of fluticasone propionate in healthy volunteers and patients with asthma

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012913

21 January 2018

Identifiers

10.1177/00912700122012913

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43836979&oldid=2144151206"